- $594.92m
- $591.86m
- $126.08m
Surmodics Inc expected to post a loss of 34 cents a share - Earnings Preview
Surmodics Inc reports results for the quarter ended in December - Earnings Summary
NASDAQ RESUMED AT 09:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Brief: Surmodics Reports First Quarter Fiscal 2022 Results
Surmodics Inc expected to post a loss of 31cents a share - Earnings Preview
Surmodics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Surmodics Reports Fourth Quarter Fiscal 2021 Results
Surmodics Inc expected to post a loss of 25 cents a share - Earnings Preview
Surmodics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Surmodics Inc Announces Successful First Patient Uses Of Sublime Radial Access .018 Rx Pta Dilatation Catheter
Surmodics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Surmodics Reports Third Quarter Fiscal 2021 Results And Updates Fiscal 2021 Revenue And EPS Guidance
Surmodics Inc expected to post a loss of 17 cents a share - Earnings Preview
Brief: Surmodics Announces Successful First Patient Use Of Pounce Thrombectomy System
Surmodics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Surmodics Reports Second Quarter Fiscal 2021 Results And Issues Fiscal 2021 Revenue And EPS Guidance
Surmodics Inc expected to post earnings of 63 cents a share - Earnings Preview
Brief: Surmodics Inc Announces Successful First Patient Uses Of Two Sublime Radial Access Platform Devices